Search Within

Shanu Modi

Formats
  1. Meeting Abstract (151)
  2. Journal Article (101)
  3. Review (12)
  4. Correspondence (2)
  5. Editorial (2)
  6. Research Letter (1)
Groups
  1. Breast Medicine Service (269)
  2. Department of Medicine (269)
  3. Solid Tumor Oncology Division (269)
  4. Survivorship Research (114)
  5. GSK Faculty (108)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (91)

More Groups

People
  1. Clifford Hudis (79)
  2. Larry Norton (53)
  3. Sarat Chandarlapaty (51)
  4. Sujata Patil (44)
  5. Chau Dang (42)
  6. Komal Jhaveri (35)

More People

Years
  1. 2025 (9)
  2. 2024 (23)
  3. 2023 (15)
  4. 2022 (19)
  5. 2021 (19)
  6. 2020 (21)

More Years

Publications
  1. Journal of Clinical Oncology (66)
  2. Cancer Research (50)
  3. Annals of Oncology (27)
  4. Breast Cancer Research and Treatment (14)
  5. Clinical Cancer Research (10)
  6. Clinical Breast Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (68)
  2. American Association for Cancer Research (64)
  3. Oxford University Press (33)
  4. Elsevier Inc. (19)
  5. Springer (19)
  6. Nature Publishing Group (13)

More Publishers

Results (269)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan (T-DXd) in patients with HER2-positive metastatic breast cancer (MBC): Updated survival results from a phase II trial (DESTINY-Breast01)
    Meeting Abstract

    Saura Manich, C.; Modi, S.; Krop, I.; Park, Y. H.; Kim, S. B.; Tamura, K.; André, F.; Iwata, H.; Ito, Y.; Tsurutani, J.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Weekly ladiratuzumab vedotin monotherapy for metastatic triple-negative breast cancer
    Meeting Abstract

    Tsai, M.; Han, H. S.; Montero, A. J.; Tkaczuk, K. H.; Assad, H.; Pusztai, L.; Hurvitz, S. A.; Wilks, S. T.; Specht, J. M.; Nanda, R.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan in previously treated HER2-positive metastatic breast cancer: Plain language summary of the DESTINY-Breast01 study
    Editorial

    Modi, S.
    Future Oncology (2021)

    Fulltext@MSK | Save
  • Pooled analysis of drug-related interstitial lung disease (ILD) in 8 single-arm trastuzumab deruxtecan (T-DXd) studies
    Meeting Abstract

    Powell, C. A.; Modi, S.; Iwata, H.; Takahashi, S.; Smit, E. F.; Siena, S.; Chang, D. Y.; Fuchs, C. S.; Nie, K.; Qin, A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: State of the art and future directions
    Review

    Ferraro, E.; Drago, J. Z.; Modi, S.
    Breast Cancer Research (2021)

    Fulltext@MSK | Save
  • A phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Drago, J. Z.; Shah, P. D.; Wang, R.; Pareja, F.; Ratzon, F.; Iasonos, A.; Patil, S.; Rosen, N.; Fornier, M. N.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Unlocking the potential of antibody - Drug conjugates for cancer therapy
    Review

    Drago, J. Z.; Modi, S.; Chandarlapaty, S.
    Nature Reviews Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Analysis of study drug-related interstitial lung disease (ILD) in patients (pts) with HER2+ metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd)
    Meeting Abstract

    Powell, C. A.; Modi, S.; Iwata, H.; Takahashi, S.; Nie, K.; Qin, A.; Singh, J.; Taitt, C.; Verma, S.; Camidge, D. R.
    Annals of Oncology (2021)

    Fulltext@MSK | Save